Ultromics EchoGo Heart Failure
Save to shortlistLast reviewed Nov 11, 2026 against the sources listed on this page · How we review
At a glance
EchoGo Heart Failure is an FDA-cleared AI diagnostic aid that detects heart failure with preserved ejection fraction (HFpEF) from a single apical four-chamber echocardiogram view, returning…
- FDA:
- 510(k) K240013 +1 more
- Epic:
- Not on record
- Named users:
- 4 named in public reports
- Published study:
- Yes, linked below
Description
EchoGo Heart Failure is an FDA-cleared AI diagnostic aid that detects heart failure with preserved ejection fraction (HFpEF) from a single apical four-chamber echocardiogram view, returning results within existing echo/PACS workflows. Developed as a University of Oxford spinout with Mayo Clinic, it demonstrated ~90% sensitivity and ~86% specificity and is cited in the 2025 ASE diastology guidelines. It holds CMS CPT Category III code 0932T for reimbursement.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Ultromics EchoGo Heart Failure FDA cleared?
- The public FDA database has 2 records that our team matched to Ultromics EchoGo Heart Failure. The most recent is 510(k) K240013 (EchoGo Heart Failure (2.0)), decided Sep 2024. Check that the cleared use matches how you plan to use it.FDA record K240013
- Which health systems use Ultromics EchoGo Heart Failure?
- Linked public reports name 4 organizations: Northwestern Medicine Bluhm Cardiovascular Institute, University Hospitals Harrington Heart & Vascular Institute, City of Hope and 1 more. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Northwestern Medicine Bluhm Cardiovascular Institute (Northwestern Medicine) University Hospitals Harrington Heart & Vascular Institute (Ultromics) City of Hope (Ultromics)
- Is there published research on Ultromics EchoGo Heart Failure?
- Yes, this listing links a published study. Check whether the patients and setting in the study look like yours.Some authors of this study work for or have financial ties to the maker.Read the study
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
- Study authors
- Include people who work for or have financial ties to the maker
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
8 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Northwestern Medicine Bluhm Cardiovascular Institute
“Bluhm Cardiovascular Institute AI portfolio” — Northwestern MedicineUniversity Hospitals Harrington Heart & Vascular Institute
“Implementing EchoGo Heart Failure: an interview with Dr. Andres Schuster” — Ultromics, Jun 2025
Reported by the developer
Last checked Nov 9, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Cardiology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
Website Research PaperSome authors of this study work for or have financial ties to the maker.
FDA database records
- K240013 · 510(k) · Sep 2024EchoGo Heart Failure (2.0)
- K222463 · 510(k) · Nov 2022EchoGo Heart Failure
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (6)Show
Dated events on this listing's public record, newest first.
- Sep 13, 2026
Added to CIFoundry
- Feb 17, 2026
News report names City of Hope as a user (Ultromics)source
- Jun 10, 2025
News report names University Hospitals Harrington Heart & Vascular Institute as a user (Ultromics)source
- Sep 23, 2024
FDA 510(k) K240013 decision datesource
- Nov 23, 2022
FDA 510(k) K222463 decision datesource
- Dec 29, 2021
News report names Northumbria Healthcare NHS FT as a user (Northumbria Healthcare)source
Developer
Ultromics Ltd. (co-founders Dr. Ross Upton and Prof. Paul Leeson)
Ultromics Ltd. (University of Oxford spinout)
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →